Article info

Download PDFPDF
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma

Authors

  1. Correspondence to Dr Marina Barcena-Varela, Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA; marina.barcena-varela{at}mssm.edu
View Full Text

Citation

Barcena-Varela M, Berraondo P
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma

Publication history

  • Received December 17, 2023
  • Accepted December 28, 2023
  • First published January 9, 2024.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.